Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

NCT03000933 ·Status: COMPLETED

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

NCT00666107 ·Status: UNKNOWN ·Phase: NA

Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination

NCT02003508 ·Status: COMPLETED

Message Framing in HPV Vaccination Decision

NCT07068802 ·Status: COMPLETED ·Phase: NA

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

NCT01651949 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of One Dose of HPV Vaccine

NCT06345885 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

NCT05314023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

NCT00309166 ·Status: COMPLETED ·Phase: PHASE2

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

NCT00513526 ·Status: COMPLETED ·Phase: PHASE2

Study on the Epidemiological Characteristics of Female HPV Vaccination in China

NCT05932563 ·Status: UNKNOWN

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

NCT05680454 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

NCT02740790 ·Status: COMPLETED ·Phase: PHASE2

Optimizing HPV Vaccine Introduction in Shanghai, China

NCT03972813 ·Status: TERMINATED ·Phase: NA

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

NCT06866574 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men

NCT04415424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

NCT04199689 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy, Immunogenicity, and Safety Study of the 9vHPV Vaccine in Japanese Males (V503-064)

NCT04635423 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

NCT00779766 ·Status: COMPLETED ·Phase: PHASE3

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

NCT04711265 ·Status: COMPLETED

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

NCT00635830 ·Status: COMPLETED ·Phase: PHASE1

Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability

NCT04945655 ·Status: COMPLETED ·Phase: NA

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

NCT04255849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

NCT05056402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

NCT00834106 ·Status: COMPLETED ·Phase: PHASE3

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

NCT01446718 ·Status: COMPLETED